HDAC9 and Ewing sarcoma: HDAC inhibitors are being evaluated as drug candidates for Ewing sarcoma (Arnaldez and Helman, 2014), but here we used them solely as a chemical biology tool for validating our gene clustering, and at much lower concentrations than if our goal were to selectively kill EWS-FLI1-expressing cells.